NasdaqGM - Nasdaq Real Time Price USD

Oculis Holding AG (OCS)

18.12
+0.84
+(4.86%)
As of 2:37:09 PM EDT. Market Open.
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
77,850
73,204
45,851
32,376
13,232
Operating Income
-77,850
-73,204
-45,851
-32,376
-13,232
Net Non Operating Interest Income Expense
1,235
1,529
114
-6,316
-5,099
Other Income Expense
-26,465
-14,262
-42,958
49
-193
Pretax Income
-103,080
-85,937
-88,695
-38,643
-18,524
Tax Provision
-183
-160
107
55
27
Net Income Common Stockholders
-102,897
-85,777
-88,802
-38,698
-18,552
Diluted NI Available to Com Stockholders
-102,897
-85,777
-88,802
-38,698
-18,552
Basic EPS
-2.37
-2.12
-2.97
-11.32
-0.57
Diluted EPS
-2.37
-2.12
-2.97
-11.32
-0.57
Basic Average Shares
43,317.04
40,406.55
29,899.65
32,733.37
32,733.37
Diluted Average Shares
43,317.04
40,406.55
29,899.65
32,733.37
32,733.37
Total Operating Income as Reported
-77,850
-73,204
-80,714
-32,376
-13,232
Total Expenses
77,850
73,204
45,851
32,376
13,232
Net Income from Continuing & Discontinued Operation
-102,897
-85,777
-88,802
-38,698
-18,552
Normalized Income
-76,478.98
-71,541.55
-49,495.43
-38,742.84
-18,387.81
Interest Income
2,080
2,168
1,429
126
21
Interest Expense
845
639
1,315
6,442
5,120
Net Interest Income
1,235
1,529
114
-6,316
-5,099
EBIT
-102,235
-85,298
-87,380
-32,201
-13,404
EBITDA
-101,779
-84,892
-87,093
-31,902
-13,169
Reconciled Depreciation
456
406
287
299
235
Net Income from Continuing Operation Net Minority Interest
-102,897
-85,777
-88,802
-38,698
-18,552
Total Unusual Items Excluding Goodwill
-26,465
-14,262
-42,958
49
-193
Total Unusual Items
-26,465
-14,262
-42,958
49
-193
Normalized EBITDA
-75,314
-70,630
-44,135
-31,951
-12,976
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-46.98
-26.55
-3,651.43
4.17
-28.81
12/31/2021 - 5/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVBP ArriVent BioPharma, Inc.
19.07
+1.71%
 
207940.KS Samsung Biologics Co.,Ltd.
998,000.00
-0.70%
 
OPT Opthea Limited
3.4100
+1.49%
 
IVA Inventiva S.A.
3.4400
-1.71%
 
BNTC Benitec Biopharma Inc.
13.55
-0.22%
 
CAMX.ST Camurus AB (publ)
543.50
-12.55%
 
XBRANE.ST Xbrane Biopharma AB (publ)
0.2444
-2.24%
 
MBX MBX Biosciences, Inc.
10.46
+2.80%
 
LENZ LENZ Therapeutics, Inc.
27.56
-0.25%
 
9EN.F Pharvaris N.V.
14.20
+1.43%